Leishmania major intracellular survival is not altered in SHP-1 deficient mev or CD45-/- mice

Experimental Parasitology

Volumn 120, Issue 3, 2008, Pages 275-279

  Späth, Gerald F ^a,b,c   McDowell, Mary Ann ^d   Beverley, Stephen M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSTITUT PASTEUR   (France)

^c INSERM   (France)

^d UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

Cellular phosphatases; Host cell signaling pathways; Immune subversion; Intracellular parasite; Leishmania major; Macrophage; Trypanosomatid protozoa

Indexed keywords

CD45 ANTIGEN; PROTEIN TYROSINE PHOSPHATASE SHP 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; LEISHMANIA MAJOR; LEISHMANIASIS; MACROPHAGE; MOUSE; NONHUMAN; PARASITE SURVIVAL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD45; CELLS, CULTURED; FEMALE; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; NITRIC OXIDE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 6; SIGNAL TRANSDUCTION; VIRULENCE;

LEISHMANIA MAJOR; MUS; PROTOZOA; TRYPANOSOMATIDAE;

EID: 53049089586     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2008.07.003     Document Type: Article

References (24)

1. Blanchette J., Pouliot P., and Olivier M. Role of protein tyrosine phosphatases in the regulation of interferon-{gamma}-induced macrophage nitric oxide generation: implication of ERK pathway and AP-1 activation. J. Leukoc. Biol. 81 (2007) 835-844
2. Blanchette J., Racette N., Faure R., Siminovitch K.A., and Olivier M. Leishmania-induced increases in activation of macrophage SHP-1 tyrosine phosphatase are associated with impaired IFN-gamma-triggered JAK2 activation. Eur. J. Immunol. 29 (1999) 3737-3744
3. Bogdan C., Rollinghoff M., and Diefenbach A. The role of nitric oxide in innate immunity. Immunol. Rev. 173 (2000) 17-26
4. Crocker P.R., Blackwell J.M., and Bradley D.J. Transfer of innate resistance and susceptibility to Leishmania donovani infection in mouse radiation bone marrow chimaeras. Immunology 52 (1984) 417-422
5. Forget G., Gregory D.J., Whitcombe L.A., and Olivier M. Role of host protein tyrosine phosphatase SHP-1 in Leishmania donovani-induced inhibition of nitric oxide production. Infect. Immun. 74 (2006) 6272-6279
6. Forget G., Siminovitch K.A., Brochu S., Rivest S., Radzioch D., and Olivier M. Role of host phosphotyrosine phosphatase SHP-1 in the development of murine leishmaniasis. Eur. J. Immunol. 31 (2001) 3185-3196
7. 15N]nitrate in biological fluids. Anal. Biochem. 126 (1982) 131-138
8. Kapler G.M., Coburn C.M., and Beverley S.M. Stable transfection of the human parasite Leishmania major delineates a 30-kilobase region sufficient for extrachromosomal replication and expression. Mol. Cell Biol. 10 (1990) 1084-1094
9. Kishihara K., Penninger J., Wallace V.A., Kundig T.M., Kawai K., Wakeham A., Timms E., Pfeffer K., Ohashi P.S., Thomas M.L., et al. Normal B lymphocyte development but impaired T cell maturation in CD45-exon6 protein tyrosine phosphatase-deficient mice. Cell 74 (1993) 143-156
10. Martiny A., Meyer-Fernandes J.R., de Souza W., and Vannier-Santos M.A. Altered tyrosine phosphorylation of ERK1 MAP kinase and other macrophage molecules caused by Leishmania amastigotes. Mol. Biochem. Parasitol. 102 (1999) 1-12
11. Matte C., Marquis J.F., Blanchette J., Gros P., Faure R., Posner B.I., and Olivier M. Peroxovanadium-mediated protection against murine leishmaniasis: role of the modulation of nitric oxide. Eur. J. Immunol. 30 (2000) 2555-2564
12. Mauel J., Ransijn A., and Buchmuller-Rouiller Y. Killing of Leishmania parasites in activated murine macrophages is based on an l-arginine-dependent process that produces nitrogen derivatives. J. Leukoc. Biol. 49 (1991) 73-82
13. Nabors G.S., Nolan T., Croop W., Li J., and Farrell J.P. The influence of the site of parasite inoculation on the development of Th1 and Th2 type immune responses in (BALB/c × C57BL/6) F1 mice infected with Leishmania major. Parasite Immunol. 17 (1995) 569-579
14. Nandan D., Yi T., Lopez M., Lai C., and Reiner N.E. Leishmania EF-1alpha activates the Src homology 2 domain containing tyrosine phosphatase SHP-1 leading to macrophage deactivation. J. Biol. Chem. 277 (2002) 50190-50197
15. Nascimento M., Zhang W.W., Ghosh A., Houston D.R., Berghuis A.M., Olivier M., and Matlashewski G. Identification and characterization of a protein-tyrosine phosphatase in Leishmania: involvement in virulence. J. Biol. Chem. 281 (2006) 36257-36268
16. Olivier M., Romero-Gallo B.J., Matte C., Blanchette J., Posner B.I., Tremblay M.J., and Faure R. Modulation of interferon-gamma-induced macrophage activation by phosphotyrosine phosphatases inhibition. Effect on murine Leishmaniasis progression. J. Biol. Chem. 273 (1998) 13944-13949
17. Racoosin E.L., and Beverley S.M. Leishmania major: promastigotes induce expression of a subset of chemokine genes in murine macrophages. Exp. Parasitol. 85 (1997) 283-295
18. Shultz L.D., Coman D.R., Bailey C.L., Beamer W.G., and Sidman C.L. "Viable motheaten," a new allele at the motheaten locus. I. Pathology. Am. J. Pathol. 116 (1984) 179-192
19. Shultz L.D., Schweitzer P.A., Rajan T.V., Yi T., Ihle J.N., Matthews R.J., Thomas M.L., and Beier D.R. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 73 (1993) 1445-1454
20. Spanopoulou E. Cellular and molecular analysis of lymphoid development using Rag-deficient mice. Int. Rev. Immunol. 13 (1996) 257-288
21. Späth G.F., Epstein L., Leader B., Singer S.M., Avila H.A., Turco S.J., and Beverley S.M. Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite Leishmania major. Proc. Natl. Acad. Sci. USA 97 (2000) 9258-9263
22. Trowbridge I.S., and Thomas M.L. CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annu. Rev. Immunol. 12 (1994) 85-116
23. Tsui F.W., and Tsui H.W. Molecular basis of the motheaten phenotype. Immunol. Rev. 138 (1994) 185-206
24. Wei G., Guo J., Doseff A.I., Kusewitt D.F., Man A.K., Oshima R.G., and Ostrowski M.C. Activated Ets2 is required for persistent inflammatory responses in the motheaten viable model. J. Immunol. 173 (2004) 1374-1379